US Stock MarketDetailed Quotes
ENZN ENZON PHARMACEUTICALS INC
- 0.150000
- -0.006300-4.03%
15min DelayClose Sep 6 16:00 ET
11.13MMarket Cap30.00P/E (TTM)
0.159800High0.140100Low55.30KVolume0.145000Open0.156300Pre Close8.21KTurnover0.18%Turnover Ratio150.00P/E (Static)74.21MShares0.24000052wk High3.19P/B4.52MFloat Cap0.06000052wk Low--Dividend TTM30.11MShs Float0.760000Historical High--Div YieldTTM12.60%Amplitude0.060000Historical Low0.148000Avg Price1Lot Size
ENZON PHARMACEUTICALS INC Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -5.12%241K | 47.65%251K | 298.03%1.31M | 250.00%455K | 634.48%426K | 140.00%254K | 180.19%170K | -31.54%-659K | 152.00%130K | 119.33%58K |
| Net income from continuing operations | 50.82%276K | 62.44%320K | 838.17%1.37M | 101.80%672K | 2,240.00%321K | 185.92%183K | 167.70%197K | 60.34%-186K | 241.70%333K | 93.36%-15K |
| Deferred tax | -92.16%4K | 97.22%-1K | 22.28%-157K | -22.77%-248K | --76K | --51K | ---36K | ---202K | ---202K | --0 |
| Change In working capital | -295.00%-39K | -855.56%-68K | 132.84%89K | 3,200.00%31K | -60.27%29K | 104.74%20K | -88.61%9K | -746.88%-271K | 93.33%-1K | 198.65%73K |
| -Change in receivables | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 221.74%28K | ---- | ---- |
| -Change in payables and accrued expense | ---- | ---- | -28.57%15K | ---- | ---- | ---- | ---- | 333.33%21K | ---- | ---- |
| -Change in other current assets | ---- | ---- | 123.13%74K | ---- | ---- | ---- | ---- | ---320K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -5.12%241K | 47.65%251K | 298.03%1.31M | 250.00%455K | 634.48%426K | 140.00%254K | 180.19%170K | -31.54%-659K | 152.00%130K | 119.33%58K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0.00%-1.28M | -1.28M | 0 | 0 | 0 | -1.28M | 0 | 0 | 0 |
| Cash dividends paid | --0 | 0.00%-1.28M | ---1.28M | --0 | --0 | --0 | ---1.28M | --0 | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | 0.00%-1.28M | ---1.28M | --0 | --0 | --0 | ---1.28M | --0 | --0 | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 0.24%45.99M | 0.06%47.01M | -1.38%46.98M | -0.63%46.56M | -1.42%46.13M | -3.27%45.88M | -1.38%46.98M | -1.04%47.64M | -2.17%46.85M | -2.90%46.79M |
| Current changes in cash | -5.12%241K | 7.33%-1.02M | 104.55%30K | 250.00%455K | 634.48%426K | 140.00%254K | -421.23%-1.11M | -31.54%-659K | 152.00%130K | 119.33%58K |
| End cash Position | 0.21%46.23M | 0.24%45.99M | 0.06%47.01M | 0.06%47.01M | -0.63%46.56M | -1.42%46.13M | -3.27%45.88M | -1.38%46.98M | -1.38%46.98M | -2.17%46.85M |
| Free cash flow | -5.12%241K | 47.65%251K | 298.03%1.31M | 250.00%455K | 634.48%426K | 140.00%254K | 180.19%170K | -31.54%-659K | 152.00%130K | 119.33%58K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg